(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202403 | 202303 | % Var | 202403 | 202303 | % Var | 202403 | 202303 | % Var | |
| Sales | 52.05 | 13.02 | 299.77 | 125.52 | 60.91 | 106.07 | 125.52 | 60.91 | 106.07 |
| Other Income | 2.73 | 2.42 | 12.81 | 4.53 | 3.82 | 18.59 | 4.53 | 3.82 | 18.59 |
| PBIDT | 2.34 | 1.31 | 78.63 | 4.09 | 3.76 | 8.78 | 4.09 | 3.76 | 8.78 |
| Interest | 0.16 | 0.20 | -20.00 | 0.35 | 0.47 | -25.53 | 0.35 | 0.47 | -25.53 |
| PBDT | 2.18 | 1.11 | 96.40 | 3.74 | 3.29 | 13.68 | 3.74 | 3.29 | 13.68 |
| Depreciation | 1.64 | 1.14 | 43.86 | 2.17 | 2.11 | 2.84 | 2.17 | 2.11 | 2.84 |
| PBT | 0.54 | -0.03 | -1900.00 | 1.57 | 1.18 | 33.05 | 1.57 | 1.18 | 33.05 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 0.54 | -0.03 | -1900.00 | 1.57 | 1.18 | 33.05 | 1.57 | 1.18 | 33.05 |
| Equity | 163.11 | 154.99 | 5.24 | 163.11 | 154.99 | 5.24 | 163.11 | 154.99 | 5.24 |
| PBIDTM(%) | 4.50 | 10.06 | -55.32 | 3.26 | 6.17 | -47.22 | 3.26 | 6.17 | -47.22 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1808.20 |
| Dr. Reddys Lab | 1322.95 |
| Cipla | 1309.90 |
| Zydus Lifesciences | 891.65 |
| Lupin | 2303.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: